Algorhythm Holdings ended its obligation to issue up to 5,000,000 common shares to Continuation Capital under a settlement tied to $1,928,014 in liabilities. For investors, the termination removes further share issuance under that agreement, while approximately $1,418,649 remains due under the covered liabilities.

Key Highlights

  • Continuation Capital acquired the liabilities covered by the settlement from their former holders.
  • Algorhythm Holdings updated its corporate presentation for investor meetings and website publication.
  • The termination ended Algorhythm Holdings’ further obligation to issue shares under the settlement.

RIME is a Movies/Entertainment company. Algorhythm Holdings, Inc. (NASDAQ: RIME) and Continuation Capital, Inc. agreed on September 21, 2026, to end a settlement arrangement covering liabilities with an original principal amount of $1,928,014. The termination stops any further obligation to issue common stock under that arrangement.

Settlement Terms and Remaining Balance

The settlement was dated July 21, 2026, and involved liabilities Continuation Capital had acquired from their former holders. Under its terms, Algorhythm Holdings could issue up to 5,000,000 common shares with a Par Value of $0.01 per share, across one or more tranches. Algorhythm Holdings estimates that approximately $1,418,649 remains payable under the liabilities covered by the settlement.

Termination Ends Additional Share Requirement

The September 21 agreement ends Algorhythm Holdings’ remaining duty to issue shares under the settlement. The stated effect applies to any further share issuance connected with that arrangement. Algorhythm Holdings also updated its corporate presentation on September 22, 2026. The company intends to use the presentation in investor meetings and publish it on its website.